{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:30:59Z","timestamp":1791437459559,"version":"4.3.3"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10792-021-01994-9","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:26:02Z","timestamp":1628529962000},"page":"295-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-5409","authenticated-orcid":false,"given":"Dimitrios","family":"Kalogeropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hercules","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Vartholomatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Malamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekanth","family":"Sreekantam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kanavaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kalogeropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"1994_CR1","doi-asserted-by":"crossref","unstructured":"Delair E, Latkany P et al (2011) Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm 19(2):91\u2013102.","DOI":"10.3109\/09273948.2011.564068"},{"key":"1994_CR2","doi-asserted-by":"crossref","unstructured":"Vallochi AL et al (2008) Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly. Clin Ophthalmol 2(4):837\u201348.","DOI":"10.2147\/OPTH.S1629"},{"issue":"4","key":"1994_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/092739490500174","volume":"12","author":"M Soheilian","year":"2004","unstructured":"Soheilian M, Heidari K, Yazdani S et al (2004) Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm 12(4):297\u2013310","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"1994_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/archophthalmol.2009.354","volume":"128","author":"MB Balasundaram","year":"2010","unstructured":"Balasundaram MB, Andavar R, Palaniswamy M et al (2010) Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol 128(1):28\u201332","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1994_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s10384-003-0069-0","volume":"48","author":"LS Atmaca","year":"2004","unstructured":"Atmaca LS, Simsek T, Batioglu F (2004) Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 48(4):386\u2013391","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"1994_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1128\/MMBR.64.3.607-623.2000","volume":"64","author":"MW Black","year":"2000","unstructured":"Black MW, Boothroyd JC (2000) Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev 64(3):607\u2013623","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"1994_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000363141","volume":"52","author":"U Pleyer","year":"2014","unstructured":"Pleyer U, Schl\u00fcter D, M\u00e4nz M (2014) Ocular toxoplasmosis: recent aspects of pathophysiology and clinical implications. Ophthalmic Res 52(3):116\u2013123","journal-title":"Ophthalmic Res"},{"issue":"9425","key":"1994_CR8","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363(9425):1965\u20131976","journal-title":"Lancet"},{"key":"1994_CR9","doi-asserted-by":"crossref","unstructured":"Holland GN. Ocular toxoplasmosis: a global reassessment: part I\u2014epidemiology and course of disease. Am J Ophthalmol. 2003;136(6):973\u201388.","DOI":"10.1016\/j.ajo.2003.09.040"},{"issue":"12","key":"1994_CR10","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S1473-3099(12)70303-1","volume":"12","author":"T Kirby","year":"2012","unstructured":"Kirby T (2012) Calls for more detailed studies on toxoplasmosis. Lancet Infect Dis 12(12):912\u2013913","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"1994_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.ijpara.2008.03.007","volume":"38","author":"JP Dubey","year":"2008","unstructured":"Dubey JP, Jones JL (2008) Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol 38(11):1257\u20131278","journal-title":"Int J Parasitol"},{"issue":"1","key":"1994_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pt.2008.09.008","volume":"25","author":"A Kijlstra","year":"2009","unstructured":"Kijlstra A, Jongert E (2009) Toxoplasma-safe meat: close to reality? Trends Parasitol 25(1):18\u201322","journal-title":"Trends Parasitol"},{"issue":"12\u201313","key":"1994_CR13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30(12\u201313):1217\u20131258","journal-title":"Int J Parasitol"},{"key":"1994_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1756-3305-5-48","volume":"5","author":"DH Zhou","year":"2012","unstructured":"Zhou DH, Zhao FR, Lu P et al (2012) Seroprevalence of Toxoplasma gondii infection in dairy cattle in southern China. Parasit Vectors 5:48","journal-title":"Parasit Vectors"},{"issue":"4","key":"1994_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s11250-011-9965-3","volume":"44","author":"D Wu","year":"2012","unstructured":"Wu D, Lv R, Sun X et al (2012) Seroprevalence of Toxoplasma gondii antibodies from slaughter pigs in Chongqing. China Trop Anim Health Prod 44(4):685\u2013687","journal-title":"China Trop Anim Health Prod"},{"key":"1994_CR16","first-page":"19","volume":"1","author":"TI Dolgikh","year":"2008","unstructured":"Dolgikh TI, Zaparii NS, Kadtsyna TV et al (2008) Epidemiological and clinicoimmunological monitoring of toxoplasmosis in the Omsk region (in Russian). Med Parazitol (Mosk) 1:19\u201322","journal-title":"Med Parazitol (Mosk)"},{"issue":"9072","key":"1994_CR17","first-page":"173","volume":"350","author":"WR Bowie","year":"1997","unstructured":"Bowie WR, King AS, Werker DH et al (1997) Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team Lancet 350(9072):173\u2013177","journal-title":"The BC Toxoplasma Investigation Team Lancet"},{"issue":"2","key":"1994_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3201\/eid1202.041115","volume":"12","author":"L de Moura","year":"2006","unstructured":"de Moura L, Bahia-Oliveira LM, Wada MY et al (2006) Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis 12(2):326\u2013329","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"1994_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00436-009-1447-4","volume":"105","author":"BG Meerburg","year":"2009","unstructured":"Meerburg BG, Kijlstra A (2009) Changing climate changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res 105(1):17\u201324","journal-title":"Parasitol Res"},{"issue":"2","key":"1994_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4161\/viru.19004","volume":"3","author":"SM Feustel","year":"2012","unstructured":"Feustel SM, Meissner M, Liesenfeld O (2012) Toxoplasma gondii and the blood-brain barrier. Virulence 3(2):182\u2013192","journal-title":"Virulence"},{"issue":"1\u20132","key":"1994_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jneuroim.2010.10.029","volume":"232","author":"SM Lachenmaier","year":"2011","unstructured":"Lachenmaier SM, Deli MA, Meissner M et al (2011) Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J Neuroimmunol 232(1\u20132):119\u2013130","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1994_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1182\/blood-2005-02-0666","volume":"107","author":"N Courret","year":"2006","unstructured":"Courret N, Darche S, Sonigo P et al (2006) CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107(1):309\u2013316","journal-title":"Blood"},{"issue":"5\u20136","key":"1994_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0463.2009.02453.x","volume":"117","author":"IJ Blader","year":"2009","unstructured":"Blader IJ, Saeij JP (2009) Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence. APMIS 117(5\u20136):458\u2013476","journal-title":"APMIS"},{"issue":"9","key":"1994_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ijpara.2013.04.004","volume":"43","author":"A Sauer","year":"2013","unstructured":"Sauer A, Rochet E, Lahmar I et al (2013) The local immune response to intraocular Toxoplasma re-challenge: less pathology and better parasite control through Treg\/Th1\/Th2 induction. Int J Parasitol 43(9):721\u2013728","journal-title":"Int J Parasitol"},{"issue":"3","key":"1994_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1086\/653738","volume":"202","author":"R Guiton","year":"2010","unstructured":"Guiton R, Vasseur V, Charron S et al (2010) Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice. J Infect Dis 202(3):427\u2013435","journal-title":"J Infect Dis"},{"issue":"6","key":"1994_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.1736","volume":"10","author":"W O\u2019Connor Jr","year":"2009","unstructured":"O\u2019Connor W Jr, Kamanaka M, Booth CJ et al (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10(6):603\u2013609","journal-title":"Nat Immunol"},{"issue":"2","key":"1994_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/cei.12219","volume":"175","author":"M Hu","year":"2014","unstructured":"Hu M, Zheng Q, Jia X et al (2014) Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL- 17-containing environment during acute neuroinflammation. Clin Exp Immunol 175(2):268\u2013284","journal-title":"Clin Exp Immunol"},{"key":"1994_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0002-9394(58)91127-9","volume":"46","author":"MJ Hogan","year":"1958","unstructured":"Hogan MJ (1958) Ocular toxoplasmosis: XIV Edward Jackson Memorial Lecture. Am J Ophthalmol 46:467\u2013494","journal-title":"Am J Ophthalmol"},{"key":"1994_CR29","doi-asserted-by":"crossref","unstructured":"Holland GN. Ocular toxoplasmosis: a global reassessment: part II\u2014disease manifestations and management. Am J Ophthalmol. 2004;137(1):1\u201317.","DOI":"10.1016\/j.ajo.2003.10.032"},{"issue":"6","key":"1994_CR30","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","volume":"172","author":"DK Howe","year":"1995","unstructured":"Howe DK, Sibley LD (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172(6):1561\u20131566","journal-title":"J Infect Dis"},{"issue":"5540","key":"1994_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1061888","volume":"294","author":"ME Grigg","year":"2001","unstructured":"Grigg ME, Bonnefoy S, Hehl AB et al (2001) Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 294(5540):161\u2013165","journal-title":"Science"},{"issue":"5605","key":"1994_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1126\/science.1078035","volume":"299","author":"C Su","year":"2003","unstructured":"Su C, Evans D, Cole RH et al (2003) Recent expansion of Toxoplasma through enhanced oral transmission. Science 299(5605):414\u2013416","journal-title":"Science"},{"issue":"16","key":"1994_CR33","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1073\/pnas.172117099","volume":"99","author":"C Su","year":"2002","unstructured":"Su C, Howe DK, Dubey JP et al (2002) Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii. Proc Natl Acad Sci USA 99(16):10753\u201310758 (Epub 2002 Jul 29)","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1994_CR34","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1084\/jem.20020258","volume":"195","author":"A Barragan","year":"2002","unstructured":"Barragan A, Sibley LD (2002) Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med 195(12):1625\u20131633","journal-title":"J Exp Med"},{"issue":"4","key":"1994_CR35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1369-5274(02)00349-1","volume":"5","author":"JC Boothroyd","year":"2002","unstructured":"Boothroyd JC, Grigg ME (2002) Population biology of Toxoplasma gondii and its relevance to human infection: Do different strains cause different disease? Curr Opin Microbiol 5(4):438\u2013442","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"1994_CR36","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1128\/JCM.39.4.1566-1570.2001","volume":"39","author":"I Fuentes","year":"2001","unstructured":"Fuentes I, Rubio JM, Ramirez C et al (2001) Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J Clin Microbiol 39(4):1566\u20131570","journal-title":"J Clin Microbiol"},{"issue":"5","key":"1994_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/322800","volume":"184","author":"ME Grigg","year":"2001","unstructured":"Grigg ME, Ganatra J, Boothroyd JC et al (2001) Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 184(5):633\u2013639","journal-title":"J Infect Dis"},{"issue":"1","key":"1994_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0020-7519(01)00364-2","volume":"32","author":"JP Dubey","year":"2002","unstructured":"Dubey JP, Graham DH, Blackston CR et al (2002) Biological and genetic characterisation of Toxoplasma gondii isolates from chickens (Gallus domesticus) from Sao Paulo, Brazil: unexpected findings. Int J Parasitol 32(1):99\u2013105","journal-title":"Int J Parasitol"},{"issue":"6986","key":"1994_CR39","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/bmj.310.6986.1037","volume":"310","author":"RE Gilbert","year":"1995","unstructured":"Gilbert RE, Stanford MR, Jackson H et al (1995) Incidence of acute symptomatic Toxoplasma retinochoroiditis in south London according to country of birth. BMJ 310(6986):1037\u20131040","journal-title":"BMJ"},{"issue":"2","key":"1994_CR40","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1542\/peds.2005-1530","volume":"118","author":"N Roizen","year":"2006","unstructured":"Roizen N, Kasza K, Karrison T et al (2006) Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics 118(2):e379\u2013e390","journal-title":"Pediatrics"},{"issue":"5","key":"1994_CR41","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","volume":"109","author":"LE Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV et al (2002) Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109(5):869\u2013878","journal-title":"Ophthalmology"},{"issue":"3","key":"1994_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/09273948.2011.581407","volume":"19","author":"DV Vasconcelos-Santos","year":"2011","unstructured":"Vasconcelos-Santos DV, Dodds EM, Orefice F (2011) Review for disease of the year: differential diagnosis of ocular toxoplasmosis. Ocul Immunol Inflamm 19(3):171\u2013179","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"1994_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0002-9394(02)01500-3","volume":"134","author":"C Fardeau","year":"2002","unstructured":"Fardeau C, Romand S, Rao NA et al (2002) Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 134(2):196\u2013203","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1994_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00055735-200212000-00008","volume":"13","author":"JR Smith","year":"2002","unstructured":"Smith JR, Cunningham ET Jr (2002) Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol 13(6):387\u2013392","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"1994_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/bjophthalmol-2015-308246","volume":"101","author":"F Pichi","year":"2017","unstructured":"Pichi F, Veronese C, Lembo A et al (2017) New appraisals of Kyrieleis plaques: a multimodal imaging study. Br J Ophthalmol 101(3):316\u2013321. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-308246","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1994_CR46","first-page":"835","volume":"29","author":"GN Holland","year":"1988","unstructured":"Holland GN, O\u2019Connor GR, Diaz RF et al (1988) Ocular toxoplasmosis in immunosuppressed nonhuman primates. Invest Ophthalmol Vis Sci 29(6):835\u2013842","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1994_CR47","first-page":"51","volume":"119","author":"F Roberts","year":"2001","unstructured":"Roberts F, Mets MB, Ferguson DJ et al (2001) Histopathological features of ocular toxoplasmosis in the fetus and infant. Arch Ophthalmol 119(1):51\u201358","journal-title":"Arch Ophthalmol"},{"key":"1994_CR48","doi-asserted-by":"crossref","unstructured":"Dutton GN, McMenamin PG, Hay J, et al. The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis: part II\u2014the morphology of the inflammatory changes. Exp Eye Res. 1986;43(4):545\u201360.","DOI":"10.1016\/S0014-4835(86)80022-7"},{"key":"1994_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2013.12.005","volume":"39","author":"M Maenz","year":"2014","unstructured":"Maenz M, Schl\u00fcter D, Liesenfeld O (2014) Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res 39:77\u2013106","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"1994_CR50","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/archophthalmol.2009.251","volume":"127","author":"EC de Souza","year":"2009","unstructured":"de Souza EC, Casella AM (2009) Clinical and tomographic features of macular punctate outer retinal toxoplasmosis. Arch Ophthalmol 127(10):1390\u20131394","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1994_CR51","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/archopht.1985.01050090084037","volume":"103","author":"BH Doft","year":"1985","unstructured":"Doft BH, Gass DM (1985) Punctate outer retinal toxoplasmosis. Arch Ophthalmol 103(9):1332\u20131336","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"1994_CR52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3928\/23258160-20190503-04","volume":"50","author":"NA Yannuzzi","year":"2019","unstructured":"Yannuzzi NA, Gal-Or O, Motulsky E et al (2019) Multimodal imaging of punctate outer retinal toxoplasmosis. Ophthalmic Surg Lasers Imaging Retina 50(5):281\u2013287. https:\/\/doi.org\/10.3928\/23258160-20190503-04","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"8","key":"1994_CR53","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0161-6420(13)31511-5","volume":"100","author":"RH Fish","year":"1993","unstructured":"Fish RH, Hoskins JC, Kline LB (1993) Toxoplasmosis neuroretinitis. Ophthalmology 100(8):1177\u20131182","journal-title":"Ophthalmology"},{"issue":"6","key":"1994_CR54","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/112067210901900635","volume":"19","author":"E Miserocchi","year":"2009","unstructured":"Miserocchi E, Modorati G, Rama P (2009) Atypical toxoplasmosis masquerading late occurrence of typical findings. Eur J Ophthalmol 19(6):1091\u20131093","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"1994_CR55","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0002-9394(88)90697-6","volume":"106","author":"GN Holland","year":"1988","unstructured":"Holland GN, Engstrom RE Jr, Glasgow BJ et al (1988) Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 106(6):653\u2013667","journal-title":"Am J Ophthalmol"},{"key":"1994_CR56","first-page":"41","volume":"69","author":"E Jensen","year":"1908","unstructured":"Jensen E (1908) Retino-chorioiditis juxtapapillaris. Arch F Ophth 69:41","journal-title":"Arch F Ophth"},{"issue":"5","key":"1994_CR57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archophthalmol.2011.1527","volume":"130","author":"DS Rudich","year":"2012","unstructured":"Rudich DS, Bhatnagar P (2012) Scleritis associated with toxoplasmic retinochoroiditis. Arch Ophthalmol 130(5):659\u2013660","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"1994_CR58","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0161-6420(88)32998-2","volume":"95","author":"JS Schuman","year":"1988","unstructured":"Schuman JS, Weinberg RS, Ferry AP et al (1988) Toxoplasmic scleritis. Ophthalmology 95(10):1399\u20131403","journal-title":"Ophthalmology"},{"issue":"6","key":"1994_CR59","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ajo.2008.09.006","volume":"146","author":"EM Dodds","year":"2008","unstructured":"Dodds EM, Holland GN, Stanford MR (2008) Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol 146(6):856\u201365.e2","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1994_CR60","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/eye.2009.140","volume":"24","author":"J Melamed","year":"2010","unstructured":"Melamed J, Eckert GU, Spadoni VS (2010) Ocular manifestations of congenital toxoplasmosis. Eye (Lond) 24(4):528\u2013534","journal-title":"Eye (Lond)"},{"issue":"6","key":"1994_CR61","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/112067210901900622","volume":"19","author":"A Adan","year":"2009","unstructured":"Adan A, Giralt J, Alvarez G et al (2009) Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis. Eur J Ophthalmol 19(6):1039\u20131043","journal-title":"Eur J Ophthalmol"},{"key":"1994_CR62","unstructured":"Sousa DC, Andrade GC, Nascimento H et al. Macular hole associated with toxoplasmosis: a surgical case series. Retin Cases Brief Rep. 2018."},{"issue":"1","key":"1994_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1869-5760-3-16","volume":"3","author":"R Kahloun","year":"2013","unstructured":"Kahloun R, Mbarek S, Khairallah-Ksiaa I et al (2013) Branch retinal artery occlusion associated with posterior uveitis. J Ophthalmic Inflamm Infect 3(1):16","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"1994_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10792-008-9291-6","volume":"30","author":"P Neri","year":"2010","unstructured":"Neri P, Mercanti L, Mariotti C et al (2010) Long-term control of choroidal neovascularization in quiescent congenital toxoplasma retinochoroiditis with photodynamic therapy: 4-year results. Int Ophthalmol 30(1):51\u201356","journal-title":"Int Ophthalmol"},{"issue":"8","key":"1994_CR65","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/archopht.126.8.1152","volume":"126","author":"JD Benevento","year":"2008","unstructured":"Benevento JD, Jager RD, Noble AG et al (2008) Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol 126(8):1152\u20131156","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1994_CR66","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/IIO.0b013e318265fd78","volume":"52","author":"D Lavinsky","year":"2012","unstructured":"Lavinsky D, Romano A, Muccioli C et al (2012) Imaging in ocular toxoplasmosis. Int Ophthalmol Clin 52(4):131\u2013143","journal-title":"Int Ophthalmol Clin"},{"key":"1994_CR67","first-page":"385","volume-title":"Diagnosis and treatment of uveitis","author":"A Pereira","year":"2001","unstructured":"Pereira A, Orefice F (2001) Toxoplasmosis. In: Foster C, Vitale A (eds) Diagnosis and treatment of uveitis. W.B Sauders Company, Philadelphia, pp 385\u2013410"},{"issue":"1","key":"1994_CR68","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1442-9071.2009.02017.x","volume":"37","author":"A Hassenstein","year":"2009","unstructured":"Hassenstein A, Meyer CH (2009) Clinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography: a review. Clin Exp Ophthalmol 37(1):130\u2013143","journal-title":"Clin Exp Ophthalmol"},{"issue":"7","key":"1994_CR69","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1167\/iovs.05-1104","volume":"47","author":"AWA Weinberger","year":"2006","unstructured":"Weinberger AWA, Lappas A, Kirschkamp T et al (2006) Fundus near infrared fluorescence correlates with fundus near infrared reflectance. Invest Ophthalmol Vis Sci 47(7):3098\u20133108","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1994_CR70","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/IAE.0b013e318164a907","volume":"28","author":"S Schmitz-Valckenberg","year":"2008","unstructured":"Schmitz-Valckenberg S, Holz FG, Bird AC et al (2008) Fundus autofluorescence imaging: review and perspectives. Retina 28(3):385\u2013409","journal-title":"Retina"},{"key":"1994_CR71","doi-asserted-by":"publisher","unstructured":"Onal S, Tugal-Tutkun I, Neri P, P Herbort C. Optical coherence tomography imaging in uveitis. Int Ophthalmol. 2014;34(2):401\u2013435. https:\/\/doi.org\/10.1007\/s10792-013-9822-7.","DOI":"10.1007\/s10792-013-9822-7"},{"key":"1994_CR72","doi-asserted-by":"publisher","unstructured":"de Oliveira Dias JR, Campelo C, Novais EA, et al. New findings useful for clinical practice using swept-source optical coherence tomography angiography in the follow-up of active ocular toxoplasmosis. Int J Retina Vitreous. 2020;6:30. https:\/\/doi.org\/10.1186\/s40942-020-00231-2.","DOI":"10.1186\/s40942-020-00231-2"},{"issue":"11","key":"1994_CR73","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1097\/IAE.0000000000000721","volume":"35","author":"RF Spaide","year":"2015","unstructured":"Spaide RF (2015) Volume rendering of optical coherence tomography angiography reveals extensive retinal vascular contributions to neovascularization in ocular toxoplasmosis. Retina 35(11):2421\u20132422. https:\/\/doi.org\/10.1097\/IAE.0000000000000721","journal-title":"Retina"},{"key":"1994_CR74","doi-asserted-by":"publisher","unstructured":"Park JH, Lee SY, Lee EK. Morphological characteristics of ocular toxoplasmosis and its regression pattern on swept-source optical coherence tomography angiography: a case report. BMC Ophthalmol. 2019;19(1):199. https:\/\/doi.org\/10.1186\/s12886-019-1209-8.","DOI":"10.1186\/s12886-019-1209-8"},{"issue":"6","key":"1994_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3928\/23258160-20170601-11","volume":"48","author":"FM T\u00fcrkc\u00fc","year":"2017","unstructured":"T\u00fcrkc\u00fc FM, \u015eahin A, Y\u00fcksel H, \u015eahin M, Karaalp \u00dc (2017) OCTA imaging of choroidal neovascular membrane secondary to toxoplasma retinochoroiditis. Ophthalmic Surg Lasers Imaging Retina 48(6):509\u2013511. https:\/\/doi.org\/10.3928\/23258160-20170601-11","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"11","key":"1994_CR76","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3109\/00365548.2012.693197","volume":"44","author":"G Saadatnia","year":"2012","unstructured":"Saadatnia G, Golkar M (2012) A review on human toxoplasmosis. Scand J Infect Dis 44(11):805\u2013811","journal-title":"Scand J Infect Dis"},{"issue":"Suppl 1","key":"1994_CR77","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1086\/338827","volume":"185","author":"J Montoya","year":"2002","unstructured":"Montoya J (2002) Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 185(Suppl 1):S73-82","journal-title":"J Infect Dis"},{"issue":"3","key":"1994_CR78","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00436-010-2245-8","volume":"108","author":"R Abdul-Ghani","year":"2011","unstructured":"Abdul-Ghani R (2011) Polymerase chain reaction in the diagnosis of congenital toxoplasmosis: more than two decades of development and evaluation. Parasitol Res 108(3):505\u2013512","journal-title":"Parasitol Res"},{"issue":"3","key":"1994_CR79","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/JCM.42.3.941-945.2004","volume":"42","author":"JS Remington","year":"2004","unstructured":"Remington JS, Thulliez P, Montoya JG (2004) Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 42(3):941\u2013945","journal-title":"J Clin Microbiol"},{"key":"1994_CR80","doi-asserted-by":"crossref","unstructured":"Bastien P. Molecular diagnosis of toxoplasmosis: transactions of the royal society of tropical medicine and hygiene. Trans R Soc Trop Med Hyg. 2002;96 Suppl 1:S205\u201315.","DOI":"10.1016\/S0035-9203(02)90078-7"},{"issue":"9","key":"1994_CR81","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/archopht.119.9.1315","volume":"119","author":"H Dabil","year":"2001","unstructured":"Dabil H, Boley ML, Schmitz TM, Van Gelder RN (2001) Validation of a diagnostic multiplex polymerase chain reaction assay for infectious posterior uveitis. Arch Ophthalmol 119(9):1315\u20131322","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1994_CR82","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1128\/JCM.02500-09","volume":"48","author":"Y Sterkers","year":"2010","unstructured":"Sterkers Y, Varlet-Marie E, Cassaing S et al (2010) Multicentric comparative analytical performance study for molecular detection of low amounts of Toxoplasma gondii from simulated specimens. J Clin Microbiol 48(9):3216\u20133222","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1994_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2334-3-7","volume":"3","author":"U Reischl","year":"2003","unstructured":"Reischl U, Bretagne S, Kr\u00fcger D et al (2003) Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 3(1):7","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1994_CR84","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ajo.2008.07.043","volume":"147","author":"T Harper","year":"2009","unstructured":"Harper T, Miller D, Schiffman J et al (2009) Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Opthalmol 147(1):140\u2013147","journal-title":"Am J Opthalmol"},{"issue":"1","key":"1994_CR85","first-page":"56","volume":"12","author":"A Farhadi","year":"2017","unstructured":"Farhadi A, Haniloo A, Fazaeli A et al (2017) PCR-based diagnosis of Toxoplasma parasite in ocular infections having clinical indications of toxoplasmosis. Iran J Parasitol 12(1):56\u201362","journal-title":"Iran J Parasitol"},{"key":"1994_CR86","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bjophthalmol-2018-313064","volume":"103","author":"C Gomez","year":"2019","unstructured":"Gomez C, Sahoo M, Kahn GY et al (2019) Dual-target, real-time PCR for the diagnosis of intraocular Toxoplasma gondii infections. Br J Opthalmol 103:569\u2013572","journal-title":"Br J Opthalmol"},{"issue":"11","key":"1994_CR87","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1128\/JCM.01793-14","volume":"52","author":"C Bourdin","year":"2014","unstructured":"Bourdin C, Busse A, Kouamou E et al (2014) PCR-based detection of Toxoplasma gondii in blood and ocular samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 52(11):3987\u20133991","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1994_CR88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/09273948.2011.595872","volume":"19","author":"G Garweg","year":"2011","unstructured":"Garweg G, Groot-Mijnes J, Montoya J (2011) Diagnostic approach to ocular toxoplasmosis. Ocul Immunol Inflamm 19(4):255\u2013261","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"1994_CR89","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/QCO.0000000000000275","volume":"29","author":"F Robert-Gangneux","year":"2016","unstructured":"Robert-Gangneux F, Belaz S (2016) Molecular diagnosis of toxoplasmosis in immunocompromised patients. Curr Opin Infect Dis 29(4):330\u2013339. https:\/\/doi.org\/10.1097\/QCO.0000000000000275","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"1994_CR90","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1128\/JCM.01900-07","volume":"46","author":"A Fekkar","year":"2008","unstructured":"Fekkar A, Bodaghi B, Touafek F, Le Hoang P, Mazier D, Paris L (2008) Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 46(6):1965\u20131967. https:\/\/doi.org\/10.1128\/JCM.01900-07","journal-title":"J Clin Microbiol"},{"key":"1994_CR91","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13071-015-0902-6","volume":"8","author":"Q Liu","year":"2015","unstructured":"Liu Q, Wang Z-D, Huang S-Y et al (2015) Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors 8:292","journal-title":"Parasit Vectors"},{"issue":"1","key":"1994_CR92","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12639-018-1063-2","volume":"43","author":"R Wassef","year":"2019","unstructured":"Wassef R, Abdel-Malek R (2019) Validity of a new immunochromatographic test in detection of Toxoplasma gondii in cancer patients. J Parasit Dis 43(1):83\u201386","journal-title":"J Parasit Dis"},{"issue":"3","key":"1994_CR93","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/08820530500231961","volume":"20","author":"AA Bonfioli","year":"2005","unstructured":"Bonfioli AA, Orefice F (2005) Toxoplasmosis. Semin Ophthalmol 20(3):129\u2013141","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"1994_CR94","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1017\/S0950268803001948","volume":"132","author":"L Gras","year":"2004","unstructured":"Gras L, Gilbert RE, Wallon M et al (2004) Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 132(3):541\u2013548","journal-title":"Epidemiol Infect"},{"key":"1994_CR95","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1051\/parasite\/2019013","volume":"26","author":"TR Olariu","year":"2019","unstructured":"Olariu TR, Press C, Talucod J et al (2019) Congenital toxoplasmosis in the United States: clinical and serologic findings in infants born to mothers treated during pregnancy. Parasite 26:13","journal-title":"Parasite"},{"key":"1994_CR96","doi-asserted-by":"crossref","unstructured":"Findal G, Pedersen-Stray B, Holter E, et al. Persistent low Toxoplasma IgG avidity is common in pregnancy: experience from antenatal testing in Norway. PLoS One. 2015;10(12):e0145519.","DOI":"10.1371\/journal.pone.0145519"},{"key":"1994_CR97","doi-asserted-by":"crossref","unstructured":"Villena ID, Aubert D, Brodard V, et al. Detection of specific immunoglobulin E during maternal, fetal, and congenital toxoplasmosis. J Clin Microbiol 1999;37(11):3487\u201390.","DOI":"10.1128\/JCM.37.11.3487-3490.1999"},{"issue":"5","key":"1994_CR98","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/aos.12851","volume":"94","author":"M Roh","year":"2016","unstructured":"Roh M, Yasa C, Cho H et al (2016) The role of serological titres in the diagnosis of ocular toxoplasmosis. Acta Ophthalmol 94(5):521\u2013522","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"1994_CR99","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10792-011-9507-z","volume":"31","author":"M Papadia","year":"2011","unstructured":"Papadia M, Aldigeri F, Herbort C (2011) The role of serology in active ocular toxoplasmosis. Int Ophthalmol 31(6):461\u2013465","journal-title":"Int Ophthalmol"},{"key":"1994_CR100","doi-asserted-by":"publisher","unstructured":"Silveira C, Vallochi AL, Rodrigues da Silva U, et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol. 2011;95(3):396\u2013400. https:\/\/doi.org\/10.1136\/bjo.2008.148205.","DOI":"10.1136\/bjo.2008.148205"},{"issue":"6","key":"1994_CR101","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF02306485","volume":"13","author":"A Kijlstra","year":"1989","unstructured":"Kijlstra A, Luyendijk L, Baarsma GS et al (1989) Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis. Int Ophthalmol 13(6):383\u2013386. https:\/\/doi.org\/10.1007\/BF02306485","journal-title":"Int Ophthalmol"},{"issue":"1","key":"1994_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000449169","volume":"57","author":"C Ozgonul","year":"2017","unstructured":"Ozgonul C, Besirli CG (2017) Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res 57(1):1\u201312. https:\/\/doi.org\/10.1159\/000449169","journal-title":"Ophthalmic Res"},{"key":"1994_CR103","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000301976","volume":"127","author":"H von Goldman","year":"1954","unstructured":"von Goldman H, Witmer R (1954) Antikoperimkammerwasser. Ophthalmologica 127:323\u2013330","journal-title":"Ophthalmologica"},{"issue":"1","key":"1994_CR104","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.diagmicrobio.2015.09.009","volume":"84","author":"O Villard","year":"2016","unstructured":"Villard O, Cimon B, L\u2019Ollivier C et al (2016) Serological diagnosis of Toxoplasma gondii infection: recommendations from the french national reference center for toxoplasmosis. Diagn Microbiol Infect Dis 84(1):22\u201333","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"1994_CR105","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ophtha.2007.05.014","volume":"115","author":"A Rothova","year":"2008","unstructured":"Rothova A, de Boer JH, Ten Dam-van Loon NH et al (2008) Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology 115(2):306\u2013311. https:\/\/doi.org\/10.1016\/j.ophtha.2007.05.014","journal-title":"Ophthalmology"},{"issue":"3","key":"1994_CR106","first-page":"735","volume":"29","author":"M Fawzy","year":"1999","unstructured":"Fawzy M, Mahmoud LA, El Gindy AE et al (1999) Value of estimating intraocular antibody production in diagnosis of typical and atypical lesions of ocular toxoplasmosis. J Egypt Soc Parasitol 29(3):735\u2013743","journal-title":"J Egypt Soc Parasitol"},{"issue":"10","key":"1994_CR107","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/bjophthalmol-2017-311528","volume":"102","author":"T Mathis","year":"2018","unstructured":"Mathis T, Beccat S, S\u00e8ve P, Peyron F, Wallon M, Kodjikian L (2018) Comparison of immunoblotting (IgA and IgG) and the Goldmann-Witmer coefficient for diagnosis of ocular toxoplasmosis in immunocompetent patients. Br J Ophthalmol 102(10):1454\u20131458. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311528","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1994_CR108","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10096-003-1048-6","volume":"23","author":"F Robert-Gangneux","year":"2004","unstructured":"Robert-Gangneux F, Binisti P, Antonetti D, Brezin A, Yera H, Dupouy-Camet J (2004) Usefulness of immunoblotting and Goldmann-Witmer coefficient for biological diagnosis of toxoplasmic retinochoroiditis. Eur J Clin Microbiol Infect Dis 23(1):34\u201338. https:\/\/doi.org\/10.1007\/s10096-003-1048-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"1994_CR109","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1128\/JCM.42.10.4593-4598.2004","volume":"42","author":"JG Garweg","year":"2004","unstructured":"Garweg JG, Garweg SD, Flueckiger F et al (2004) Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M, and E in cases of human ocular toxoplasmosis. J Clin Microbiol 42(10):4593\u20134598","journal-title":"J Clin Microbiol"},{"key":"1994_CR110","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s13104-015-1650-6","volume":"8","author":"M Previato","year":"2015","unstructured":"Previato M, Frederico FB, Murata FH et al (2015) A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis. BMC Res Notes 8:746","journal-title":"BMC Res Notes"},{"issue":"1","key":"1994_CR111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1128\/JCM.01903-09","volume":"48","author":"E Chapey","year":"2010","unstructured":"Chapey E, Wallon M, Debize G, Rabilloud M, Peyron F (2010) Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J Clin Microbiol 48(1):41\u201345. https:\/\/doi.org\/10.1128\/JCM.01903-09","journal-title":"J Clin Microbiol"},{"key":"1994_CR112","doi-asserted-by":"publisher","unstructured":"de Ara\u00fajo TE, Dos Santos LI, Gomes AO, et al. Putative biomarkers for early diagnosis and prognosis of congenital ocular toxoplasmosis. Sci Rep. 2020;10(1):16757. https:\/\/doi.org\/10.1038\/s41598-020-73265-z.","DOI":"10.1038\/s41598-020-73265-z"},{"key":"1994_CR113","doi-asserted-by":"publisher","unstructured":"Meira CS, Pereira-Chioccola VL, Vidal JE, et al. Cerebral and ocular toxoplasmosis related with IFN-\u03b3, TNF-\u03b1, and IL-10 levels. Front Microbiol. 2014;5:492. https:\/\/doi.org\/10.3389\/fmicb.2014.00492.","DOI":"10.3389\/fmicb.2014.00492"},{"key":"1994_CR114","doi-asserted-by":"crossref","unstructured":"Gross U. Pr\u00e4valenz und Public-Health-Aspekte der Toxoplasmose. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2004;1;47(7):692\u20137.","DOI":"10.1007\/s00103-004-0859-7"},{"issue":"6","key":"1994_CR115","first-page":"384","volume":"34","author":"S Bidgoli","year":"2011","unstructured":"Bidgoli S, Koch P, Caspers L (2011) Toxoplasmic chorioretinitis: positive PCR on vitreous with negative serology for Toxoplasma gondii. J Fran\u00e7aisd\u2019ophtalmologie 34(6):384-e1","journal-title":"J Fran\u00e7aisd'ophtalmologie"},{"issue":"6","key":"1994_CR116","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/ICU.0b013e328358bae5","volume":"23","author":"DV Vasconcelos-Santos","year":"2012","unstructured":"Vasconcelos-Santos DV (2012) Ocular manifestations of systemic disease: toxoplasmosis. Curr Opin Ophthalmol 23(6):543\u201350","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"1994_CR117","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/archopht.1952.00920010132001","volume":"48","author":"HC Wilder","year":"1952","unstructured":"Wilder HC (1952) Toxoplasma chorioretinitis in adults. AMA Arch Ophthalmol 48(2):127\u201336","journal-title":"AMA Arch Ophthalmol"},{"issue":"4","key":"1994_CR118","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","volume":"115","author":"A Rothova","year":"1993","unstructured":"Rothova A, Meenken C, Buitenhuis HJ et al (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115(4):517\u201323","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1994_CR119","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1590\/S0074-02762009000200027","volume":"104","author":"MR Stanford","year":"2009","unstructured":"Stanford MR, Gilbert RE (2009) Treating ocular toxoplasmosis: current evidence. Mem Inst Oswaldo Cruz 104(2):312\u20135","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1994_CR120","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/B978-012369542-0\/50009-X","volume-title":"Toxoplasma gondii: the model apicomplexan\u2014perspectives and methods","author":"U Reichard","year":"2007","unstructured":"Reichard U, Gross U (2007) Toxoplasma animal models and therapeutics. In: Weiss LM, Kim K (eds) Toxoplasma gondii: the model apicomplexan\u2014perspectives and methods. Amsterdam, Elsevier Academic Press, pp 153\u2013184"},{"key":"1994_CR121","first-page":"680","volume-title":"Uve\u0131tis\u2014Cl\u0131nica e Cirurgica","author":"F Orefice","year":"2000","unstructured":"Orefice F, Bonfioli AA (2000) Toxoplasmosis. In: Orefice F (ed) Uve\u0131tis\u2014Cl\u0131nica e Cirurgica, 1st edn. CulturaMedica, Rio de Janeiro, pp 680\u2013784","edition":"1"},{"issue":"1","key":"1994_CR122","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","volume":"134","author":"GN Holland","year":"2002","unstructured":"Holland GN, Lewis KG (2002) An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 134(1):102\u201314","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"1994_CR123","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","volume":"112","author":"M Soheilian","year":"2005","unstructured":"Soheilian M, Sadoughi MM, Ghajarnia M et al (2005) Prospective randomized trial of trimethoprim\/ sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 112(11):1876\u201382","journal-title":"Ophthalmology"},{"issue":"1","key":"1994_CR124","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","volume":"134","author":"C Silveira","year":"2002","unstructured":"Silveira C, Belfort R Jr, Muccioli C et al (2002) The effect of long-term intermittent trimethoprim\/ sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134(1):41\u20136","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1994_CR125","first-page":"58","volume":"28","author":"S Lam","year":"1993","unstructured":"Lam S, Tessler HH (1993) Quadruple therapy for ocular toxoplasmosis. Can J Ophthalmol 28(2):58\u201361","journal-title":"Can J Ophthalmol"},{"key":"1994_CR126","unstructured":"Martinez CE, Zhang D, Conway MD, et al. Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine. Int Ophthalmol. 1998\u20131999;22(2):85\u20138."},{"issue":"3","key":"1994_CR127","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3928\/1542-8877-20010501-03","volume":"32","author":"K Kishore","year":"2001","unstructured":"Kishore K, Conway MD, Peyman GA (2001) Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers 32(3):183\u201392","journal-title":"Ophthalmic Surg Lasers"},{"issue":"9","key":"1994_CR128","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.ophtha.2010.01.028","volume":"117","author":"AF Lasave","year":"2010","unstructured":"Lasave AF, Diaz-Llopis M, Muccioli C et al (2010) Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months. Ophthalmology 117(9):1831\u20138","journal-title":"Ophthalmology"},{"key":"1994_CR129","doi-asserted-by":"crossref","unstructured":"Soheilian M, Ramezani A, Azimzadeh A, et al. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis Ophthalmology. 2011;118(1):134\u201341.","DOI":"10.1016\/j.ophtha.2010.04.020"},{"issue":"1","key":"1994_CR130","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1442-9071.2012.02838.x","volume":"41","author":"NJ Butler","year":"2013","unstructured":"Butler NJ, Furtado JM, Winthrop KL et al (2013) Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol 41(1):95\u2013108","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"1994_CR131","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1001\/archophthalmol.2011.331","volume":"129","author":"ET Cunningham Jr","year":"2011","unstructured":"Cunningham ET Jr, Hubbard LD, Danis RP et al (2011) Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis. Arch Ophthalmol 129(11):1507\u20138","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1994_CR132","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","volume":"134","author":"LH Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MS et al (2002) A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol 134(1):34\u201340","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1994_CR133","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/bjo.82.8.858","volume":"82","author":"EH Bosch-Driessen","year":"1998","unstructured":"Bosch-Driessen EH, Rothova A (1998) Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Br J Ophthalmol 82(8):858\u201360","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1994_CR134","first-page":"811","volume":"83","author":"RA Nozik","year":"1977","unstructured":"Nozik RA (1977) Results of treatment of ocular toxoplasmosis with injectable corticosteroids. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 83(5):811\u20138","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"1994_CR135","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/sj.eye.6702113","volume":"20","author":"FB Aggio","year":"2006","unstructured":"Aggio FB, Muccioli C, Belfort R Jr (2006) Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis. Eye (Lond) 20:1080\u20132","journal-title":"Eye (Lond)"},{"key":"1994_CR136","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/eye.2008.5","volume":"22","author":"O Backhouse","year":"2008","unstructured":"Backhouse O, Bhan KJ, Bishop F (2008) Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis. Eye (Lond) 22:1201\u20132","journal-title":"Eye (Lond)"},{"key":"1994_CR137","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.actatropica.2018.04.026","volume":"185","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Lin X, Lu F (2018) Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis. Acta Trop 185:52\u201362","journal-title":"Acta Trop"},{"issue":"5","key":"1994_CR138","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1442-9071.2005.01061.x","volume":"33","author":"LI Kump","year":"2005","unstructured":"Kump LI, Androudi SN, Foster CS (2005) Ocular toxoplasmosis in pregnancy. Clin Exp Ophthalmol 33(5):455\u201360","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"1994_CR139","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1471-0528.2004.00302.x","volume":"112","author":"JG Garweg","year":"2005","unstructured":"Garweg JG, Scherrer J, Wallon M, Kodjikian L, Peyron F (2005) Reactivation of ocular toxoplasmosis during pregnancy. BJOG 112(2):241\u2013242. https:\/\/doi.org\/10.1111\/j.1471-0528.2004.00302.x","journal-title":"BJOG"},{"issue":"4","key":"1994_CR140","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya JG, Remington JS (2008) Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 47(4):554\u2013566. https:\/\/doi.org\/10.1086\/590149","journal-title":"Clin Infect Dis"},{"key":"1994_CR141","unstructured":"Holland, GN.; O'Connor, GR.; Belfort, R., Junior; Remington, JS. Toxoplasmosis. In: Pepose, JS.; Holland, GN.; Wilhelmus, KR., editors. Ocular infection and immunity. St. Louis: Mosby; 1996. p. 1183\u2013223."},{"issue":"6","key":"1994_CR142","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ajo.2008.01.023","volume":"145","author":"GN Holland","year":"2008","unstructured":"Holland GN, Crespi CM, ten Dam-van LN et al (2008) Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol 145(6):1007\u20131013","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1994_CR143","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0002-9394(14)73706-7","volume":"111","author":"RE Engstrom Jr","year":"1991","unstructured":"Engstrom RE Jr, Holland GN, Nussenblatt RB, Jabs DA (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111(5):601\u201310","journal-title":"Am J Ophthalmol"},{"key":"1994_CR144","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.2147\/OPTH.S51740","volume":"7","author":"I Asproudis","year":"2013","unstructured":"Asproudis I, Koumpoulis I, Kalogeropoulos C et al (2013) Case report of a neonate with ocular toxoplasmosis due to congenital infection: estimation of the percentage of ocular toxoplasmosis in Greece caused by congenital or acquired infection. Clin Ophthalmol 7:2249\u201352","journal-title":"Clin Ophthalmol"},{"key":"1994_CR145","doi-asserted-by":"crossref","unstructured":"Stillwaggon E, Carrier CS, Sautter M, et al. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis. 2011;5(9):e1333.","DOI":"10.1371\/journal.pntd.0001333"},{"key":"1994_CR146","doi-asserted-by":"crossref","unstructured":"Gilbert RE, Freeman K, Lago EG, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277.","DOI":"10.1371\/journal.pntd.0000277"},{"key":"1994_CR147","first-page":"385","volume-title":"Diagnosis and treatment of uveitis","author":"AP da Mata","year":"2002","unstructured":"da Mata AP, Orefice F (2002) Toxoplasmosis. In: Foster CS, Vitale AT (eds) Diagnosis and treatment of uveitis. WB Saunders, Philadelphia, pp 385\u2013410"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01994-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01994-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01994-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:26:58Z","timestamp":1744190818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01994-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1994"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01994-9","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"9 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The correct version of Figure 7 (b, c, d) is updated","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}